Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PARP inhibition modulates mitochondrial morphology and metabolism under hypoxic stress in cancer cells.

Cell death & disease·2026
Same author

Ku70-SAP domain has an overlapping function with DNA-PKcs in limiting the lateral movement of the Ku ring along DNA.

Nucleic acids research·2026
Same author

Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of life.

Journal of psychiatric research·2026
Same author

Decreasing Microtubule Detyrosination Improves Cardiac Mechanics and Sodium Channel Function in Arrhythmogenic Cardiomyopathy.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Deciphering protein mutation-phenotype linkages from CRISPR-based tiling mutagenesis screens.

Cell systems·2026
Same author

Mapping the genetic landscape of the DNA damage response with Cas12a-based combinatorial knockout screens.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 11, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K

Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.

Xiaohui Lin1, Dipika Gupta2, Alina Vaitsiankova3

  • 1Institute for Cancer Genetics, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY 10032, USA.

Molecular Cell
|October 9, 2024
PubMed
Summary
This summary is machine-generated.

Catalytically inactive Poly (ADP-ribose) polymerase 2 (PARP2) causes erythropoietic failure by impeding DNA ligation during replication. This explains PARP inhibitor-induced anemia and leukemia linked to TP53 and CHK2.

Keywords:
5′p-nicksLig1PARP inhibitionPARP inhibitorPARP2anemiaerythropoiesishematological toxicity

More Related Videos

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

14.9K
Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

17.0K

Related Experiment Videos

Last Updated: Jun 11, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

14.9K
Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

17.0K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Biology

Background:

  • Poly (ADP-ribose) polymerase inhibitors (PARPi) show promise in cancer therapy but are associated with severe anemia and leukemia.
  • PARPi function by inhibiting PARP1/2 enzymatic activity and trapping PARP proteins at DNA lesions.

Purpose of the Study:

  • To investigate the underlying mechanisms of PARPi-induced anemia and leukemia.
  • To elucidate the specific roles of PARP2 catalytic activity and DNA lesion binding in erythropoiesis.

Main Methods:

  • Utilized Parp2 knockout and catalytically inactive Parp2 mutant mice (Parp2EA/EA).
  • Analyzed erythropoiesis, DNA replication, and DNA damage response pathways.
  • Investigated the interaction of PARP2 with DNA ligases (Lig1 and Lig3) at 5'-phosphorylated nicks.

Main Results:

  • Mice with inactive PARP2 (Parp2EA/EA) exhibited TP53- and Chk2-dependent erythropoietic failure, unlike Parp2-/- mice.
  • PARP2 is robustly activated during DNA replication and specifically recruited to 5'-phosphorylated nicks, including Okazaki fragment junctions.
  • Inactive PARP2, but not its absence or active form, interferes with Lig1 and Lig3 activity, leading to replication fork collapse in erythroblasts.

Conclusions:

  • PARP2 possesses a critical structural function at 5'-phosphorylated nicks, essential for DNA ligation during replication.
  • PARP2 inactivation, particularly its catalytic inactivity, disrupts erythropoiesis and explains PARPi-induced anemia.
  • The findings highlight the role of TP53 and CHK2 in mediating the detrimental effects of PARP2 dysfunction and suggest a mechanism for the selection of TP53/CHK2 loss in cancer treatment.